These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Intravenous contrast material and acute kidney injury: a need for caution. Mirrakhimov AE; Mirrakhimov EM Radiology; 2015 Jun; 275(3):931. PubMed ID: 25997138 [No Abstract] [Full Text] [Related]
4. No Association between Intravenous Contrast Material Exposure and Adverse Clinical Outcome: Are Prevention Protocols Effective? Gramberg MC; Penne EL Radiology; 2015 Oct; 277(1):306. PubMed ID: 26402500 [No Abstract] [Full Text] [Related]
5. Intravenous contrast material exposure is not an independent risk factor for dialysis or mortality. McDonald RJ; McDonald JS; Carter RE; Hartman RP; Katzberg RW; Kallmes DF; Williamson EE Radiology; 2014 Dec; 273(3):714-25. PubMed ID: 25203000 [TBL] [Abstract][Full Text] [Related]
6. Incidences of acute kidney injury, dialysis, and graft loss following intravenous administration of low-osmolality iodinated contrast in patients with kidney transplants. Fananapazir G; Troppmann C; Corwin MT; Nikpour AM; Naderi S; Lamba R Abdom Radiol (NY); 2016 Nov; 41(11):2182-2186. PubMed ID: 27377897 [TBL] [Abstract][Full Text] [Related]
7. Contrast-induced nephropathy in outpatients with preexisting renal impairment: a comparison between intravenous iohexol and iodixanol. Cernigliaro JG; Haley WE; Adolphson DP; Jepperson MA; Crook JE; Thomas CS; Parker AS Clin Imaging; 2016; 40(5):902-6. PubMed ID: 27183138 [TBL] [Abstract][Full Text] [Related]
8. Comparison of iodixanol and iohexol in patients undergoing intravenous pyelography: a prospective controlled study. Chuang FR; Chen TC; Wang IK; Chuang CH; Chang HW; Ting-Yu Chiou T; Cheng YF; Lee WC; Chen WC; Yang KD; Lee CH Ren Fail; 2009; 31(3):181-8. PubMed ID: 19288321 [TBL] [Abstract][Full Text] [Related]
9. Clinical and nephrologic tolerance of iopromide and iotrolan in computed tomography. Langer M; Langer R; Zwicker C; Speck U; Jänicke UA; Felix R Invest Radiol; 1991 Nov; 26 Suppl 1():S83-5; discussion S88-91. PubMed ID: 1808156 [No Abstract] [Full Text] [Related]
10. Comparison of the nephrotoxicity between ioversol and iohexol. Hayami S; Ishigooka M; Suzuki Y; Hashimoto T; Nakada T; Mitobe K Int Urol Nephrol; 1996; 28(5):615-9. PubMed ID: 9061418 [TBL] [Abstract][Full Text] [Related]
11. Renal effects of nonionic contrast media after intravenous cardiac, and lumbar aortic injections. Jakobsen JA; Kolbenstvedt AN; Levorstad K; Berg KJ; Enge I Invest Radiol; 1990 Sep; 25 Suppl 1():S135-6. PubMed ID: 2283233 [No Abstract] [Full Text] [Related]
12. Is the use of intravenous contrast material truly safe in patients with impaired renal function? Cohen MD Radiology; 2009 May; 251(2):613; author reply 613-4. PubMed ID: 19401587 [No Abstract] [Full Text] [Related]
13. The rabbit renal toxicity test: a sensitive in vivo test for the nephrotoxicity of contrast agents. Pettersson G; Towart R; Grant D; Thyberg K; Golman K Acad Radiol; 2002 May; 9 Suppl 1():S62-4. PubMed ID: 12019897 [No Abstract] [Full Text] [Related]
14. Selective injection of iopentol, iohexol and metrizoate into the left coronary artery of the dog. Induction of ventricular fibrillation and decrease of aortic pressure. Almén T; Bååth L Acta Radiol Suppl; 1987; 370():65-8. PubMed ID: 2980315 [TBL] [Abstract][Full Text] [Related]
15. Rate of major adverse renal or cardiac events with iohexol compared to other low osmolar contrast media during interventional cardiovascular procedures. McCullough PA; Todoran TM; Brilakis ES; Ryan MP; Gunnarsson C Catheter Cardiovasc Interv; 2019 Feb; 93(2):E90-E97. PubMed ID: 30280476 [TBL] [Abstract][Full Text] [Related]
16. Within-hospital and 30-day outcomes in 107,994 patients undergoing invasive coronary angiography with different low-osmolar iodinated contrast media. LaBounty TM; Shah M; Raman SV; Lin FY; Berman DS; Min JK Am J Cardiol; 2012 Jun; 109(11):1594-9. PubMed ID: 22440116 [TBL] [Abstract][Full Text] [Related]
17. Contrast-agent-induced acute renal dysfunction--is iodixanol the answer? Sandler CM N Engl J Med; 2003 Feb; 348(6):551-3. PubMed ID: 12571263 [No Abstract] [Full Text] [Related]
18. A prospective, double-blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention. Nie B; Cheng WJ; Li YF; Cao Z; Yang Q; Zhao YX; Guo YH; Zhou YJ Catheter Cardiovasc Interv; 2008 Dec; 72(7):958-65. PubMed ID: 19021282 [TBL] [Abstract][Full Text] [Related]
19. Exposure to low- vs iso-osmolar contrast agents reduces NADPH-dependent reactive oxygen species generation in a cellular model of renal injury. Netti GS; Prattichizzo C; Montemurno E; Simone S; Cafiero C; Rascio F; Stallone G; Ranieri E; Grandaliano G; Gesualdo L Free Radic Biol Med; 2014 Mar; 68():35-42. PubMed ID: 24300339 [TBL] [Abstract][Full Text] [Related]
20. Influence of the timing of cardiac catheterization and the amount of contrast media on acute renal failure after cardiac surgery. Ranucci M; Ballotta A; Kunkl A; De Benedetti D; Kandil H; Conti D; Mollichelli N; Bossone E; Mehta RH Am J Cardiol; 2008 Apr; 101(8):1112-8. PubMed ID: 18394443 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]